Members |
targetComponentId |
Ambrosia psilostachya pollen allergen |
Ambrosia psilostachya pollen |
Ambulation and gait training |
Ambulation training |
Ambulation and gait training |
Gait training procedure |
Ambulation and gait training |
Ambulation training |
Ambulation and gait training |
Gait training procedure |
Amebiasis |
Infection caused by Entamoeba histolytica |
Amebiasis |
Amebic infection |
Amebiasis |
Amebic dysentery (disorder) |
Amebicide therapeutic role |
Antiprotozoal therapeutic role |
Amegakaryocytic thrombocytopenia with congenital malformation |
Amegakaryocytic thrombocytopenia with congenital malformation |
Amegakaryocytic thrombocytopenia with congenital malformation |
Thrombocytopenic purpura |
Amelia of lower limb |
Congenital complete absence of lower limb |
Amelia of lower limb |
Intrauterine amputation of lower limb |
Amelia of lower limb |
Transverse deficiency lower limb - hip level |
Amelia of upper limb |
Congenital amputation of upper limb |
Amelia of upper limb |
Congenital absence of upper limb |
Amelia of upper limb |
Congenital complete absence of upper limb (disorder) |
île des Samoa américaines |
Island in region of American Samoa |
île des Samoa américaines |
American Samoa |
American avocet |
Recurvirostra americana (organism) |
American beech pollen allergen |
American beech pollen |
American black skimmer |
Rynchops niger (organism) |
American cutaneous leishmaniasis (& [Chiclero ulcer]) |
Infection caused by Leishmania mexicana (disorder) |
American oyster-catcher |
Haematopus palliatus (organism) |
Amethyst starling |
Cinnyricinclus leucogaster |
Amidostomum species |
Amidostomum |
amikacine 100 mg/2 mL, pour injection pédiatrique |
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
amikacine 250 mg/mL, fiole d'une solution injectable |
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Amikacin sulfate 100mg/2mL powder |
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Amiloride and loop diuretic adverse reaction |
Amiloride adverse reaction |
Amiloride and loop diuretic adverse reaction |
Loop diuretic adverse reaction |
Amiloride and thiazide diuretic adverse reaction |
Amiloride adverse reaction |
Amiloride and thiazide diuretic adverse reaction |
Thiazide diuretic adverse reaction |
Amiloride hydrochloride 5mg/5mL s/f oral solution |
Product containing precisely amiloride hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Aminoacyl-histidine dipeptidase deficiency |
Deficiency of aminoacyl-histidine dipeptidase |
Aminoacyl-histidine dipeptidase deficiency |
Carnosinemia (disorder) |
Aminoacyl-histidine dipeptidase deficiency |
Hyper-beta-carnosinaemia |
Aminoacyl-histidine dipeptidase deficiency |
Carnosinuria (disorder) |
Aminoacyl-histidine dipeptidase deficiency |
Deficiency of aminoacyl-histidine dipeptidase |
Aminoacyl-histidine dipeptidase deficiency |
Carnosinuria (disorder) |
Aminoacyl-histidine dipeptidase deficiency |
Carnosinemia (disorder) |
Aminobacter species |
Aminobacter |
Aminoglycosides poisoning |
Poisoning caused by antibacterial aminoglycoside (disorder) |
acide aminosalicylique |
Para-aminosalicylate |
acide aminosalicylique |
Para-aminosalicylic acid |
Amiodarone hydrochloride 30mg/mL injection solution 10mL prefilled syringe |
Amiodarone hydrochloride 30 mg/mL solution for injection |
chlorhydrate d'amiodarone 50 mg/mL, ampoule de 3 mL de concentré pour perfusion |
Product containing precisely amiodarone hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Amiodarone hydrochloride 50mg/mL solution |
Product containing precisely amiodarone hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Amisulpride 100mg/mL s/f oral solution |
Amisulpride 100 mg/mL oral solution |
Amisulpride 100mg/mL s/f oral solution |
Amisulpride 100 mg/mL oral solution |
Amitriptyline 25mg/5mL s/f oral solution |
Product containing precisely amitriptyline hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Amitriptyline 50mg/5mL s/f oral solution |
Product containing precisely amitriptyline hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Amitriptyline hydrochloride 25mg m/r capsule |
Amitriptyline hydrochloride 25 mg prolonged-release oral capsule |
Amitriptyline hydrochloride 50mg m/r capsule |
Amitriptyline hydrochloride 50 mg prolonged-release oral capsule |
Amniocentesis with complication, without blame |
Amniocentesis |
Amniocentesis: [diagnostic] or [NEC] |
Diagnostic amniocentesis |
Amniotic cavity infection (& [membranitis] or [placentitis]) |
Infection of amniotic cavity |
Amniotic fluid analysis for erythroblastosis fetalis |
Amniotic fluid analysis for erythroblastosis fetalis |
Amniotic fluid analysis for erythroblastosis fetalis |
Amniotic fluid analysis for hemolytic disease of the newborn |
Amniotic fluid embolism following abortive pregnancy |
Induced termination of pregnancy complicated by amniotic fluid embolism (disorder) |
Amniotic fluid embolism following molar AND/OR ectopic pregnancy |
Amniotic fluid embolism due to and following ectopic pregnancy (disorder) |
Amniotic fluid embolism following molar AND/OR ectopic pregnancy |
Amniotic fluid embolism due to and following molar pregnancy |
Amniotic fluid pulmonary surfactant test |
Shake test |
Amniotic fluid pulmonary surfactant test |
Pulmonary surfactant test |
Amniotic fluid pulmonary surfactant test |
Amniotic fluid pulmonary surfactant test |
Amniotic fluid pulmonary surfactant test |
Foam stability test |
Amniotic fluid sample |
Amniotic fluid specimen |
Amniotic fluid sample |
Amniocentesis fluid specimen (specimen) |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Lecithin detected in amniotic fluid |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Sphingomyelin detected in amniotic fluid |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Lecithin detected in amniotic fluid |
Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Sphingomyelin detected in amniotic fluid |
Amniotic membrane perforator, reusable |
Amnihook, device (physical object) |
Amniotic membrane perforator, single-use |
Amnihook, device (physical object) |
Amniotome, reusable |
Amnihook, device (physical object) |
Amniotome, single-use |
Amnihook, device (physical object) |
Amniotomy at delivery |
Amniotomy at delivery (procedure) |
Amniotomy at delivery |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy at delivery |
Artificial rupture of membranes (procedure) |
Amniotomy by nurse |
Amniotomy at delivery (procedure) |
Amniotomy by nurse |
Artificial rupture of membranes (procedure) |
Amniotomy by nurse |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Induction of labor by artificial rupture of membranes (procedure) |
Amniotomy to induce labor |
Sweeping of membrane (procedure) |
Amniotomy to induce labor |
Surgical induction of labor |
Amniotomy to induce labor |
Amniotomy at delivery (procedure) |
Amniotomy to induce labor |
Artificial rupture of membranes (procedure) |
Amoeba species |
Amoeba |
Amoebiasis |
Infection caused by Entamoeba histolytica |
Amoebiasis |
Amebic infection |
Amoebiasis |
Amebic dysentery (disorder) |
Amoebiasis affecting skin |
Amoebiasis of skin |
Amoebiasis affecting skin |
Amebic ulcer of skin (disorder) |
Amoxicillin + clavulanate potassium adverse reaction |
Adverse reaction to amoxicillin and/or clavulanic acid |
Amoxicillin and clavulanate |
Product containing amoxicillin and clavulanic acid (medicinal product) |
amphétamine |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
Amphetamine and cocaine |
Product containing cocaine (medicinal product) |
Amphetamine and cocaine |
Product containing amfetamine (medicinal product) |
Amphetamine or psychostimulant |
Psychostimulant (substance) |
Amphetamine or psychostimulant |
Amfetamine and/or amfetamine derivative |
Amphetamine overdose |
Amfetamine and/or amfetamine derivative overdose (disorder) |